238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
21.74%
Net income growth above 1.5x META's 10.17%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
13.55%
D&A growth well above META's 11.33%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5185.25%
Slight usage while META is negative at -271.20%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5185.25%
Growth well above META's 93.48%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-225.51%
Negative yoy while META is 175.76%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
1.91%
Operating cash flow growth below 50% of META's 6.39%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-157.29%
Both yoy lines negative, with META at -27.80%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
100.00%
Acquisition growth of 100.00% while META is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
58.29%
Some yoy expansion while META is negative at -95.19%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
-65.12%
We reduce yoy sales while META is 198.35%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
-9.48%
Both yoy lines negative, with META at -29.73%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
4871.14%
Issuance growth of 4871.14% while META is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
No Data
No Data available this quarter, please select a different quarter.